Why Partner with GVK BIO for In Vivo Studies
1Partnering ApproachYour research partner needs to understand your vision. That is why you place a strong emphasis on working closely with your contract R&D company to develop appropriate or ‘fit-for-purpose’ study designs to meet your key objectives. With emphasis on communication, GVK BIO can work with you in lock step on your path to drug discovery.
2Holistic ApproachOur cohesive approach of bringing together scientific expertise from In Vivo pharmacology and toxicology to your projects would help in advancing best compounds more successfully in your drug discovery programs.
3Quickness in DeliveryOur team takes a systematic approach to advance your NCEs or large molecules in appropriate animal models. Most importantly, we help ensure your compound works in a relevant and accepted disease model.
4Quality AnimalsDifferent rodent species used for In Vivo pharmacology studies and toxicity studies are procured from internationally reputed vendors such as Taconic and Charles River who have established breeding facilities locally in Hyderabad.
5Wide Customer BaseWe have the experience in working on vast range of requirements from our client base that includes large, mid-size pharma and virtual companies across globe. We are sensitive to the requirements of each of these segments.
In Vivo Pharmacology Models for CVMD
GVK BIO’s In Vivo pharmacology team has a strong expertise in supporting drug discovery in the area of cardiovascular and metabolic diseases.
GVK BIO offers a range of developed and well characterised target engagement/efficacy models of Type 1 and Type 2 diabetes, obesity, renal diseases, with a particular focus on NASH (hepatic fibrosis). In addition, our team routinely develop models to fit our collaborator’s specific project needs.
In Vivo Pharmacology Models for Pain & Inflammation
GVK BIO’s scientists have in-depth knowledge and expertise in a wide range of rodent models in pain and inflammation. Wide range of inflammatory and pain (acute & chronic) have been developed and validated. The studies are conducted in a blinded fashion to avoid any bias.
In Vivo Pharmacology Models for Oncology
GVK BIO has a long-standing expertise in oncology, including contributing to multiple clinical candidates. GVK BIO offers a range of xenograft & syngeneic coupled with broad range of bio-marker read-outs.
In Vivo Pharmacology Models for Fibrosis
GVK BIO scientists have developed acute & chronic fibrosis models of Liver, Kidney and Lungs. The models have been validated known reference compounds and are supported by bio-marker, clinical chemistry and histopathology analysis.